Blog
How Italian cannabis growers defend the legality of their activities in the courts
The Regional Administrative Court of the Lazio region has suspended the implementation of a government regulation that included oral CBD preparations in the table of narcotic drugs.
What can we learn from the American experience in bringing natural CBD food products and various supplements to the market?
In the United States, at the moment, there is a situation in which , while preparing the regulatory framework for the implementation of the pharmacological drug “Epidiolex” in the country, government officials not only have a certain paradigm of thinking that needs to be changed in the future in connection with the entry of natural cannabidiol into the market, not in as a pharmaceutical raw material, but as a component of food products or various additives. The main problem is that, while forming the regulatory framework “for themselves”, pharmacologists introduce novelties into the legislation, which further prevent the use of drug-free cannabinoids in other extremely high-margin markets.
Reasons why the French CBD flower market is slipping
The ambiguous reaction to the decision of the Council of State of France by officials of various ministries and departments who are trying at the level of departmental regulations to impose restrictions on the sale of leaves and inflorescences of technical cannabis of a therapeutic orientation leads to the fact that in 2023 French hemp growers for the most part do not plan to cultivate plants rich in therapeutically active elements in order to sell them in CBD stores .
US Plant Cannabinoid Market Trends
In the United States, such segments of the hemp business exploiting the therapeutic properties of the plant as food, drinks, various supplements, body care products, and pet products are actively developing. After years of triple-digit growth in the US market for plant-based industrial cannabidiol, the market is set to stabilize starting in 2022 . At the moment, the most popular non-drug drugs on the US market cannabinoid is the plant cannabidiol. There is a growing market for “minor” cannabinoids derived from the hemp plant.
Who prevents legislators in Chile from regulating the self-cultivation of medical cannabis by patients
The lobbying structures of Chile, realizing that a potential buyer of pharmacological preparations that exploit the medicinal properties of the hemp plant in order to improve the quality of the therapeutically active hemp elements used and significantly reduce the price, will be able to legally grow plants in their own households, blocked the adoption of such changes in the current legislation.
The American market in 2023 already needs not so much therapeutic properties as hemp grains and trusts
While plant-based cannabidiol (CBD) is getting the most media attention, the market for fiber, bonfires, and grains is booming at the federal level and potentially poised for exponential growth. Unfortunately, the timing of the increase in market demand specifically for the above components of the hemp plant coincides with a downward trend in both licensed areas and investor sentiment associated with the crisis in the CBD market.
What are CBD transdermal patches for
The big advantage of this kind of patches is that they produce a permanent effect that can last longer and treat various diseases intensively. Another benefit of using cannabinoids transdermal patches is their bioavailability . Transdermal products have higher bioavailability rates , that is, the percentage of cannabinoids used in the product that are effectively absorbed by a person increases significantly if this particular method of “delivery” of therapeutically active elements of plant origin into the body is used.
In Canada, a third of childhood poisonings are associated with THC
The results show that legal psychoactive cannabis or its derivatives are currently the leading cause of hospital admissions for poisoning children in Canada. In particular, after the legalization of the use of foods containing a significant amount of THC in the provinces of Ontario, Alberta and British Columbia, the number of hospitalizations as a result of psychoactive poisoning cannabis has more than doubled.
US FDA to be reviewed due to inaction on hemp as well as plant-based cannabidiol
The US FDA Commissioner will have to appear before the House Oversight Committee of the US Congress for a thorough debriefing over the lack of action regarding the regulation of hemp-derived cannabidiol.
Marijuana companies are the main lobbyists for the legalization of its use in the US
The main lobbyists for changes in the current US legislation are companies whose activities are aimed at regulating the use of the hemp plant for medical and recreational purposes. Those. companies exploiting various properties of plants lobby primarily their own interests, completely ignoring the requests of other market participants, as well as end consumers, including blocking the possibility of regulating the cultivation of plants in households.